The epidemic situation of HIV-infection in the Russian Federation in 2022
- Authors: Ladnaia N.N.1, Pokrovsky V.V.1, Sokolova E.V.2
-
Affiliations:
- Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
- Central Research Institute of Epidemiology, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being
- Issue: Vol 13, No 3 (2023)
- Pages: 13-19
- Section: Epidemic Situation
- URL: https://journals.eco-vector.com/2226-6976/article/view/625002
- DOI: https://doi.org/10.18565/epidem.2023.13.3.13–19
- ID: 625002
Cite item
Open Access
Access granted
Abstract
Objective. Analysis of the epidemic situation of HIV infection in the Russian Federation by the end of 2022 to monitor the epidemic process and the influence of ongoing activities.
Materials and methods. The data of long-term dynamic monitoring of the characteristics of the epidemic process of HIV infection in Russia, carried out in 1987–2022, were summarized at the Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being on the basis of reporting and accounting forms of statistical observation.
Results. By the end of 2022, 1,168,076 people lived in the country with a laboratory-confirmed diagnosis of HIV infection, excluding 461,879 patients who died during the entire follow-up period. In 2022, 45,037,376 blood samples from Russian citizens were tested for HIV, which was 10.9% more than in 2021. The incidence rate of HIV infection in the Russian Federation increased by 3.8% compared to 2021 and 2020 and amounted to 43.29 cases per 100 thousand population. In 2022, 63,150 new cases of HIV infection and death of 34,410 HIV-infected Russians were reported. The total number of people living with HIV continues to grow, the prevalence of HIV infection as of December 31, 2022 was 794.7 cases per 100,000 population. Active transmission of HIV infection was observed both among the general population of reproductive age through heterosexual sexual intercourse, and in traditional risk groups.
Conclusion. The effectiveness of antiretroviral therapy in the context of HIV prevention remains insufficient, mainly due to the significant number of HIV-infected people who are not covered by medical care and a significant proportion of patients with an unsuppressed viral load.
Keywords
Full Text
About the authors
Natalia N. Ladnaia
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Author for correspondence.
Email: nladnaia@hotmail.com
ORCID iD: 0000-0003-2994-151X
Cand. Biol. Sci., Senior Researcher
Russian Federation, MoscowVadim V. Pokrovsky
Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being
Email: pokrovsky.vad@yandex.ru
ORCID iD: 0000-0002-9514-7288
Professor, Academician of the Russian Academy of Sciences, MD, Head, Specialized Research Department of Epidemiology and Prevention of AIDS
Russian Federation, MoscowEkaterina V. Sokolova
Central Research Institute of Epidemiology, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being
Email: ekaterinasokolova007@rambler.ru
ORCID iD: 0000-0002-2001-8772
Cand. Med. Sci., Researcher
Russian Federation, MoscowReferences
- Информационный бюллетень – Глобальная статистика по ВИЧ. ЮНЭЙДС, 2022. https://www.unaids.org/ru/resources/fact-sheet [Fact Sheet – Global HIV & AIDS statistics]. UNAIDS, 2022. (In Russ.). https://www.unaids.org/ru/resources/fact-sheet
- End Inequalities. End AIDS. Global AIDS Strategy 2021–2026. UNAIDS, Geneva, 2021. 100 p. https://www.unaids.org/sites/default/files/media_ asset/global-AIDS-strategy-2021-2026_en.pdf
- О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2021 году: Государственный доклад. М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2022. 340 с. https://www.rospotrebnadzor. ru/documents/details.php?ELEMENT_ID=21796 [On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2021: State report]. Moscow, 2022. 340 p. (In Russ.). https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ ID= 21796
- Ладная Н.Н., Покровский В.В., Соколова Е.В., Чекрыжова Д.Г., Киржанова В.В. Распространение инфекции, вызываемой вирусом иммунного дефицита человека, на территориях Российской Федерации в 2021 г. Эпидемиол. инфекц. болезни. Актуал. вопр. 2022; 12(3): 12–8. doi: 10.18565/epidem.2022.12.3.12-8 Ladnaia N.N., Pokrovsky V.V., Sokolova E.V., Chekryzhova D.G., Kirzhanova V.V. [Prevalence of human immune deficiency virus infection in the territories of the Russian Federation in 2021]. Epidemiology and Infectious diseases. Current items 2022; 12(3): 12–8. (In Russ.). doi: 10.18565/epidem.2022.12.3.12-8
- Численность населения Российской Федерации по полу и возрасту на 1 января 2022 года. Статистический бюллетень, Москва: Росстат, 2022. https://rosstat.gov.ru/storage/mediabank/Bul_chislen_nasel-pv_01-01-2022. pdf [Population of the Russian Federation by sex and age as of January 1, 2022. Statistical Bulletin]. Moscow: Rosstat, 2022. (In Russ.). https://rosstat. gov.ru/storage/mediabank/Bul_chislen_nasel-pv_01-01-2022. pdf
- Соколова Е.В., Ладная Н.Н., Покровский В.В., Кравченко А.В., Козырина Н.В., Юрин О.Г. и др. Влияние антиретровирусной терапии на развитие эпидемии ВИЧ-инфекции в Российской Федерации Эпидемиол. инфекц. болезни. Актуал. вопр. 2023; 13(3): 20–6. doi: 10.18565/epidem.2023.13.3.20–6 Sokolova E.V., Ladnaia N.N., Pokrovsky V.V., Kravchenko A.V., Kozyrina N.V., Yurin O.G. et al. [Influence of antiretroviral therapy on the development of the HIV epidemic in the Russian Federation]. Epidemiology and infectious diseases. Current items 2023; 13(3): 20–6. (In Russ.). doi: 10.18565/epidem.2023.13.3. 20–6
- Котова Е.Г., Кобякова О.С., Стародубов В.И., Александрова Г.А., Голубев Н.А., Кучерявая Д.А. и др. Социальнo значимые заболевания населения России в 2021 году: статистические материалы. М.: ЦНИИОИЗ Минздрава России, 2022. 77 с. Kotova E.G., Kobyakova O.S., Starodubov V.I., Aleksandrova G.A., N.A. Golubev N.A., Kutcheryavaya D.A. et al. [Socially significant diseases of the population of Russia in 2021: statistical materials]. Moscow, 2022. 77 p.
- Доля ВИЧ-инфицированных лиц, получающих антиретровирусную терапию, от числа состоящих на диспансерном учете. ЕМИСС, 2023. https://www.fedstat.ru/indicator/43860 [Proportion of HIV-infected persons receiving antiretroviral therapy from the number of those registered with the dispensary]. EMISS, 2023. (In Russ.). https://www.fedstat.ru/indicator/43860
- Число зарегистрированных больных с впервые в жизни установленным диагнозом ВИЧ-инфекции. ЕМИСС, 2023. https://www.fedstat.ru/ indicator/41719 [Number of registered patients diagnosed with HIV infection for the first time in their lives]. EMISS, 2023. (In Russ.). https://www.fedstat.ru/ indicator/41719
Supplementary files
